Search hospitals > Oklahoma > Oklahoma City

University of Oklahoma Health Sciences Center

Claim this profile
Oklahoma City, Oklahoma 73104
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Tumors
Conducts research for Leukemia
Conducts research for Ovarian Cancer
1225 reported clinical trials
90 medical researchers
Photo of University of Oklahoma Health Sciences Center in Oklahoma CityPhoto of University of Oklahoma Health Sciences Center in Oklahoma CityPhoto of University of Oklahoma Health Sciences Center in Oklahoma City

Summary

University of Oklahoma Health Sciences Center is a medical facility located in Oklahoma City, Oklahoma. This center is recognized for care of Cancer, Recurrence, Tumors, Leukemia, Ovarian Cancer and other specialties. University of Oklahoma Health Sciences Center is involved with conducting 1,225 clinical trials across 1,273 conditions. There are 90 research doctors associated with this hospital, such as Rene Y. McNall-Knapp, Debra L. Richardson, Kathleen Moore, M.D., MS, and Raid Aljumaily.

Area of expertise

1Cancer
Global Leader
University of Oklahoma Health Sciences Center has run 346 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Recurrence
Global Leader
University of Oklahoma Health Sciences Center has run 161 trials for Recurrence. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at University of Oklahoma Health Sciences Center

Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Lung Cancer
Breast Cancer
Esophageal Carcinoma
Cancer
Non-Small Cell Lung Cancer
Esophageal Cancer
Gastric Cancer
Brain Tumor
Image of trial facility.

Chemotherapy + Radiotherapy

for Esophageal and Gastric Cancer

This study is evaluating whether the addition of radiation therapy to chemotherapy may help treat patients with esophageal and gastric cancer.
Recruiting2 awards Phase 320 criteria
Image of trial facility.

Proton Therapy vs Photon Radiation

for Esophageal Cancer

This study is evaluating whether a type of radiation therapy may be more effective than another type of radiation therapy in treating esophageal cancer.
Recruiting2 awards Phase 31 criteria
Image of trial facility.

Chemotherapy + Immunotherapy

for Esophageal and Gastric Cancer

This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting2 awards Phase 32 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Oklahoma Health Sciences Center?
University of Oklahoma Health Sciences Center is a medical facility located in Oklahoma City, Oklahoma. This center is recognized for care of Cancer, Recurrence, Tumors, Leukemia, Ovarian Cancer and other specialties. University of Oklahoma Health Sciences Center is involved with conducting 1,225 clinical trials across 1,273 conditions. There are 90 research doctors associated with this hospital, such as Rene Y. McNall-Knapp, Debra L. Richardson, Kathleen Moore, M.D., MS, and Raid Aljumaily.
Where is University of Oklahoma Health Sciences Center located?
The University of Oklahoma Health Sciences Center hospital is located at 700 NE 13th St, Oklahoma City, OK 73104, at the northwest corner of the intersection of NE 13th St and Lincoln Blvd.
Who should I call to ask about financial aid or insurance network?
The University of Oklahoma Health Sciences Center (OUHSC) provides financial assistance for eligible patients needing emergency or medically necessary care. Patients can apply for this assistance via the OUHSC website and are advised to confirm their insurance coverage by contacting their physician's office directly. For billing inquiries related to OU Health Physicians Tulsa, contact (918) 660-3650 or (918) 619-4400 for assistance in Spanish.
What insurance does University of Oklahoma Health Sciences Center accept?
The University of Oklahoma Health Sciences Center (OUHSC) and OU Health Physicians accept a broad spectrum of insurance plans, including but not limited to Aetna, Blue Cross Blue Shield, Cigna Healthcare, United Healthcare, and MultiPlan/PHCS. Coverage by some plans may vary by location, notably between Oklahoma City and Tulsa. Patients are advised to verify their insurance acceptance with the specific physician's office and consult OU Health hospitals and ERs for comprehensive insurance information.
What awards or recognition has University of Oklahoma Health Sciences Center received?
The University of Oklahoma Health Sciences Center, located in Oklahoma City, Oklahoma, is a premier healthcare research institution, with researchers securing over $140 million in sponsored funding annually since 2017. It houses the Stephenson Cancer Center, the only National Cancer Institute (NCI)-Designated Cancer Center in Oklahoma, offering access to the latest investigational drugs and clinical trials for cancer treatment. Additionally, the Harold Hamm Diabetes Center provides extensive clinical trials and volunteer opportunities for diabetes research.